Please ensure Javascript is enabled for purposes of website accessibility

Weekly Cannabis Stock News: Scotts Miracle-Gro Keeps Growing, Cronos Buys Lord Jones

By Eric Volkman – Aug 5, 2019 at 9:27AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The supplier to the cannabis stars posts strong quarterly results, as does Aphria. Meanwhile, Cronos goes shopping at the beauty counter.

Last week landed smack in the thick of earnings season, and consequently, several companies in the marijuana sector reported their latest fundamentals. Happily, these were largely encouraging.

Outside of that, there was some dealmaking in the sector, which investors also greeted positively. So in contrast to last week, with its cannabis company CEO firings and regulatory warnings, this one was generally sunnier for marijuana stock investors.

Marijuana leaf with sun shining behind it

Image source: Getty Images

Scotts Miracle-Gro keeps growing

Arguably the best picks-and-shovels play among marijuana stocks, Scotts Miracle-Gro (SMG 3.60%) posted double-digit growth in key fundamentals in its latest quarter.

The gardening equipment and supplies company posted its fiscal third-quarter 2019 results. These showed that revenue grew like a wild weed, rising 18% on a year-over-year basis to just under $1.2 billion. Non-GAAP (adjusted) net income came in 17% higher at $176 million ($3.11 per share). Both figures trumped analyst estimates; on average, these were for $1.07 billion on the top line and earnings per share (EPS) of $2.74.

Better, as far as marijuana stock investors are concerned, the company's Hawthorne unit -- which supplies products used by cannabis growers -- was a big driver of growth. The division's organic sales during the quarter rose by 49%.

Finally, the company upped its full-year adjusted net profit guidance for not the first, but the second time in fiscal 2019. It now believes adjusted EPS will come in at $4.35 to $4.50, on the back of 16% to 17% sales growth.

Scotts Miracle-Gro is in the right place and right time to benefit from the sharp expansion of the cannabis growing industry. Given the dynamics of the market and the company's solid position, its expected (and continued) double-digit growth is eminently achievable.

Aphria Q4 -- surprising success

Another marijuana stock posting on the quarterly scoreboard this week was Aphria (APHA). The Canadian company flipped to a solid profit on the bottom line, while showing impressive revenue growth.

Said revenue was up by nearly 1,000% year over year in the company's fourth quarter of fiscal 2019, to CA$129 million. Net profit was nearly CA$16 million, which shook out to CA$0.05 per share and was in vivid contrast to the Q4 2018 net loss of CA$5 million (CA$0.04). These improvements were on the back of an over four-fold rise in kilos and kilogram equivalents sold, which in the latest quarter stood at 5,574.

The great bulk of the revenue growth, at least, was due to its recent acquisition of CC Pharma (a German medical marijuana distributor). But the performance of that unit was baked into estimates; the fact that Aphria still exceeded expectations was very heartening. Its efforts at brand building, efficiency, and a concentration on core strengths appear to be working.

No wonder Aphria stock was an outperformer this week. From Monday to Friday, its price rose by 33%.

Cronos acquires Lord Jones CBD personal care products

This week wasn't all about quarterly updates in the cannabis sector; there was some dealmaking, too.

Cronos Group (CRON 13.51%) announced it reached an agreement to buy the CBD-based skincare and beauty products line operated by Redwood Holding Group under the brand name Lord Jones.

Cronos is parting with around $300 million to buy Lord Jones. Most of this ($225 million) is to be transacted in cash, the rest to be settled in Cronos stock. The deal is expected to close some time this calendar quarter.

As Redwood is a privately held company, we don't have a fix on how it's doing financially, and in its press release on the acquisition, Cronos didn't provide many clues. Regardless, Lord Jones has positioned itself as a premium brand, apparently with success -- its products have been written up in publications such as The New York Times, and several celebrities are known to be devotees.

Besides, Cronos is one of those rare marijuana companies with a relatively high cash pile; it held CA$2.4 billion at the end of its most recently reported quarter. So the company is spending well within its means to acquire a highly complementary asset with some consumer cachet. Knowing what we know, then, this seems like a smart move for Cronos.


Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Scotts Miracle-Gro Company Stock Quote
The Scotts Miracle-Gro Company
$45.19 (3.60%) $1.57
Cronos Group Stock Quote
Cronos Group
$3.36 (13.51%) $0.40
Aphria Inc. Stock Quote
Aphria Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.